Kempf D J, de Lara E, Stein H H, Cohen J, Plattner J J
Cardiovascular Research Division, Abbott Laboratories, Abbott Park, Illinois 60064.
J Med Chem. 1987 Nov;30(11):1978-83. doi: 10.1021/jm00394a008.
The design and synthesis of renin inhibitors that incorporate the novel dipeptide isostere (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhex-1-ene-2-carboxylic acid as a transition-state analogue are described. Titanium-promoted condensation of dilithiated N-alkylmethacrylamides with protected amino aldehydes results in efficient preparation of protected dipeptide analogues 7 and 8. Incorporation of 7 into the partial sequence of angiotensinogen affords potent in vitro inhibitors of human renin. Further chemical manipulation of the unsaturated amide moiety allows the study of structure-activity relationships in both the P1' and P2' sites. Details of the syntheses, stereochemical determinations, and in vitro renin inhibition are presented.
本文描述了将新型二肽电子等排体(4S,5S)-5-氨基-6-环己基-4-羟基己-1-烯-2-羧酸作为过渡态类似物的肾素抑制剂的设计与合成。钛促进的二锂化N-烷基甲基丙烯酰胺与受保护的氨基醛的缩合反应可高效制备受保护的二肽类似物7和8。将7并入血管紧张素原的部分序列可得到有效的人肾素体外抑制剂。对不饱和酰胺部分进行进一步的化学操作,可研究P1'和P2'位点的构效关系。文中给出了合成、立体化学测定及体外肾素抑制的详细信息。